Cargando…

The Interface of Tumour-Associated Macrophages with Dying Cancer Cells in Immuno-Oncology

Tumour-associated macrophages (TAMs) are essential players in the tumour microenvironment (TME) and modulate various pro-tumorigenic functions such as immunosuppression, angiogenesis, cancer cell proliferation, invasion and metastasis, along with resistance to anti-cancer therapies. TAMs also mediat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vanmeerbeek, Isaure, Govaerts, Jannes, Laureano, Raquel S., Sprooten, Jenny, Naulaerts, Stefan, Borras, Daniel M., Laoui, Damya, Mazzone, Massimiliano, Van Ginderachter, Jo A., Garg, Abhishek D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9741298/ https://www.ncbi.nlm.nih.gov/pubmed/36497148 http://dx.doi.org/10.3390/cells11233890

Ejemplares similares

Necroptosis in Immuno-Oncology and Cancer Immunotherapy
por: Sprooten, Jenny, et al.
Publicado: (2020)

Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology
por: Vanmeerbeek, Isaure, et al.
Publicado: (2020)

Trial watch: chemotherapy-induced immunogenic cell death in oncology
por: Sprooten, Jenny, et al.
Publicado: (2023)

Single cell dynamics of tumor specificity vs bystander activity in CD8(+) T cells define the diverse immune landscapes in colorectal cancer
por: Borràs, Daniel Morales, et al.
Publicado: (2023)

A first-in-class, non-invasive, immunodynamic biomarker approach for precision immuno-oncology
por: Sprooten, Jenny, et al.
Publicado: (2022)

Trial watch: Dendritic cell (DC)-based immunotherapy for cancer
por: Laureano, Raquel S, et al.
Publicado: (2022)

Hypoxia and tumor-associated macrophages: A deadly alliance in support of tumor progression
por: Van Overmeire, Eva, et al.
Publicado: (2014)

Mechanisms Driving Macrophage Diversity and Specialization in Distinct Tumor Microenvironments and Parallelisms with Other Tissues
por: Van Overmeire, Eva, et al.
Publicado: (2014)

Functional Relationship between Tumor-Associated Macrophages and Macrophage Colony-Stimulating Factor as Contributors to Cancer Progression
por: Laoui, Damya, et al.
Publicado: (2014)

Peripherally-driven myeloid NFkB and IFN/ISG responses predict malignancy risk, survival, and immunotherapy regime in ovarian cancer
por: Sprooten, Jenny, et al.
Publicado: (2021)

IFNγ signaling response in peripheral blood monocytes: A new prognostic biomarker for breast cancer?
por: Deschoemaeker, Sofie, et al.
Publicado: (2020)

Immuno-Oncology
por: Chaudhuri, Swapna
Publicado: (2017)

Targeting Neuropilin-1 with Nanobodies Reduces Colorectal Carcinoma Development
por: De Vlaeminck, Yannick, et al.
Publicado: (2020)

Type I interferons and endoplasmic reticulum stress in health and disease
por: Sprooten, Jenny, et al.
Publicado: (2020)

Immuno‐Oncology in China
por: Lu, Shun, et al.
Publicado: (2019)

Radiomics in immuno-oncology
por: Bodalal, Z., et al.
Publicado: (2021)

The Role of Radiation Oncology in Immuno‐Oncology
por: Meng, Xiangjiao, et al.
Publicado: (2019)

Efficacy of CD40 Agonists Is Mediated by Distinct cDC Subsets and Subverted by Suppressive Macrophages
por: Murgaski, Aleksandar, et al.
Publicado: (2022)

The tumour microenvironment harbours ontogenically distinct dendritic cell populations with opposing effects on tumour immunity
por: Laoui, Damya, et al.
Publicado: (2016)

Immuno-Oncology Medicines: Policy Implications and Economic Considerations
por: Adunlin, Georges, et al.
Publicado: (2019)

In Vivo Inhibition of c-MYC in Myeloid Cells Impairs Tumor-Associated Macrophage Maturation and Pro-Tumoral Activities
por: Pello, Oscar M., et al.
Publicado: (2012)

Mevalonate Metabolism in Immuno-Oncology
por: Gruenbacher, Georg, et al.
Publicado: (2017)

Immuno-Oncology Essentials: An Overview
por: Hoffner, Brianna
Publicado: (2019)

Multiplex imaging in immuno-oncology
por: Zhao, Chen, et al.
Publicado: (2023)

Systemic Reprogramming of Monocytes in Cancer
por: Kiss, Máté, et al.
Publicado: (2020)

E-cadherin expression in macrophages dampens their inflammatory responsiveness in vitro, but does not modulate M2-regulated pathologies in vivo
por: Van den Bossche, Jan, et al.
Publicado: (2015)

Challenges and Opportunities in Dose Finding in Oncology and Immuno‐oncology
por: Ji, Yan, et al.
Publicado: (2018)

Dendritic Cell Vaccines: A Promising Approach in the Fight against Ovarian Cancer
por: Caro, Aarushi Audhut, et al.
Publicado: (2022)

Immuno-Imaging to Predict Treatment Response in Infection, Inflammation and Oncology
por: Signore, Alberto, et al.
Publicado: (2019)

Statistical issues and challenges in immuno-oncology
por: Chen, Tai-Tsang
Publicado: (2013)

Immunotherapies and Combination Strategies for Immuno-Oncology
por: Barbari, Cody, et al.
Publicado: (2020)

Immuno-oncology for B-cell lymphomas
por: Choi, Yoon Seok
Publicado: (2021)

Virus-Based Immuno-Oncology Models
por: Sitta, Juliana, et al.
Publicado: (2022)

Organoids as an Enabler of Precision Immuno-Oncology
por: Zhao, Junzhe, et al.
Publicado: (2023)

Single-Cell Analysis in Immuno-Oncology
por: Christodoulou, Maria-Ioanna, et al.
Publicado: (2023)

The Role of PRMT5 in Immuno-Oncology
por: Abe, Yoshinori, et al.
Publicado: (2023)

Racing CARs to veterinary immuno-oncology
por: Cockey, James R., et al.
Publicado: (2023)

Exercise Oncology and Immuno-Oncology; A (Future) Dynamic Duo
por: Holmen Olofsson, Gitte, et al.
Publicado: (2020)

Interventional Oncology and Immuno-Oncology: Current Challenges and Future Trends
por: Posa, Alessandro, et al.
Publicado: (2023)

Diamonds in the Rough: Harnessing Tumor-Associated Myeloid Cells for Cancer Therapy
por: Clappaert, Emile J., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4fun1pijor7htebvi96e48fgir